Skip to search formSkip to main contentSkip to account menu

HspE7

Known as: HPV 16 E7/HSP65 Vaccine, Verpasep Caltespen, BCG65-E7 
A recombinant chimeric protein composed of the heat shock protein 65 (Hsp65) from Mycobacterium bovis, and the human papilloma viral (HPV) protein E7… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Cervical intraepithelial neoplasia (CIN) II, III is a preinvasive stage of squamous cell carcinoma of the uterine cervix. The… 
2007
2007
ABSTRACT Infection with human papillomavirus type 16 (HPV16) is strongly associated with a number of disease states, of which… 
2007
2007
  • M. Bayes
  • Methods and findings in experimental and clinical…
  • 2007
  • Corpus ID: 25431539
Agomelatine, AGRO-100, AIDSVAX gp120 B/E, alfimeprase, aliskiren fumarate, ALVAC vCP1452, alvocidib hydrochloride, ambrisentan… 
Highly Cited
2005
Highly Cited
2005
Objectives: We sought to evaluate the effectiveness of HspE7, a recombinant fusion protein of Hsp65 from Mycobacterium bovis BCG… 
Review
2005
Review
2005
Stressgen is developing HspE7, a recombinant fusion protein comprising the human papillomavirus (HPV) E7 antigen and the heat… 
Review
2002
Review
2002
AbstractPURPOSE: Human papillomavirus causes anogenital squamous intraepithelial lesions, warts, and cancer. Treatment of… 
2001
2001
  • S. Hunt
  • Current opinion in molecular therapeutics
  • 2001
  • Corpus ID: 40214286
StressGen is developing HspE7 (SGN-00101) as a potential therapy for human papillomavirus (HPV)-associated conditions. It is a… 
2000
2000
Abstract Human papillomavirus type 16 (HPV16) infection has been linked to the development of cervical and anal dysplasia and…